Musculoskeletal
1692 — Guy Patin's referenced case, France; 1740 formal account by John Freke, England
Fibrodysplasia ossificans progressiva was a rare condition in which soft tissues gradually transformed into bone, a process that historical physicians observed with bewilderment and described in terms reflecting the medical frameworks of their respective eras. Early accounts portrayed affected individuals as turning to stone, and for centuries the condition resisted coherent explanation within prevailing theories of disease. Its history traced a slow arc from mythologized case reports through anatomical curiosity to eventual molecular understanding.
Historical Narrative
The earliest encounters between physicians and what would later be identified as fibrodysplasia ossificans progressiva were recorded in the seventeenth century, when European medical literature began accumulating case reports of individuals whose muscles and connective tissues appeared to ossify progressively over the course of their lives. These accounts carried an air of the extraordinary, and affected individuals were sometimes described in terms more suited to legend than medicine, evoking classical myths of human transformation into stone or wood.
The French physician Guy Patin offered one of the earliest documented references in 1692, describing a patient whose body appeared to be hardening progressively. In the following decades, additional case reports emerged from across Europe, and the condition began attracting the attention of anatomists who were eager to examine affected individuals post-mortem. The physical evidence found during dissections, revealing bone formation within muscles and other soft tissues, was startling enough to be reported in the transactions of learned societies and to circulate among natural philosophers as an example of the body's most mysterious capacities.
In the eighteenth century, the English surgeon John Freke presented a detailed account before the Royal Society in 1740, describing a fourteen-year-old boy whose back and shoulders were infiltrated by bony masses growing from the spine outward across the musculature. Freke's report is now recognized as one of the most significant early clinical descriptions of the condition. His careful anatomical observations placed the case firmly within the emerging tradition of empirical medicine even as he struggled to explain the underlying mechanism, attributing the ossification to an excess of a bone-forming principle operating outside its normal boundaries.
Throughout the nineteenth century, as pathological anatomy became increasingly systematized in Paris, Vienna, and London, additional cases were gathered and compared. The condition acquired various names in this period, including myositis ossificans progressiva, a term that reflected the prevailing assumption that inflammation of muscle was the primary driver. This nomenclature, though later recognized as imprecise in its emphasis on muscular inflammation, persisted for many decades in medical literature and textbooks.
Among the most historically significant skeletal specimens associated with the condition was the skeleton of Harry Eastlack, who came under medical observation in the mid-twentieth century in the United States. Eastlack, who had been affected from childhood, donated his skeleton to science before his death in 1973, and it subsequently became housed at the Mütter Museum of the College of Physicians of Philadelphia. His remains became one of the most studied physical artifacts in the history of the condition and played a direct role in guiding later laboratory investigation.
The twentieth century brought a gradual separation of fibrodysplasia ossificans progressiva from other forms of heterotopic ossification. Researchers including Michael Zasloff and Frederick Kaplan, working at the University of Pennsylvania in the late twentieth and early twenty-first centuries, undertook the molecular investigations that eventually traced the condition to mutations in a receptor involved in bone morphogenetic protein signaling. This discovery, arriving in 2006, represented the culmination of nearly three centuries of clinical observation and represented a profound shift in how the condition's biological basis was understood by the medical community.
Key Historical Figures
Historical narrative only — this page describes how Fibrodysplasia ossificans progressiva was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.